Wang Yan, Liu Bing, Min Qingjie, Yang Xin, Yan Shi, Ma Yuanyuan, Li Shaolei, Fan Jiawen, Wang Yaqi, Dong Bin, Teng Huajing, Lin Dongmei, Zhan Qimin, Wu Nan
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.
Cell Discov. 2023 Sep 19;9(1):96. doi: 10.1038/s41421-023-00591-7.
Indolent (lepidic) and aggressive (micropapillary, solid, and poorly differentiated acinar) histologic subtypes often coexist within a tumor tissue of lung adenocarcinoma (LUAD), but the molecular features associated with different subtypes and their transitions remain elusive. Here, we combine spatial transcriptomics and multiplex immunohistochemistry to elucidate molecular characteristics and cellular plasticity of distinct histologic subtypes of LUAD. We delineate transcriptional reprogramming and dynamic cell signaling that determine subtype progression, especially hypoxia-induced regulatory network. Different histologic subtypes exhibit heterogeneity in dedifferentiation states. Additionally, our results show that macrophages are the most abundant cell type in LUAD, and identify different tumor-associated macrophage subpopulations that are unique to each histologic subtype, which might contribute to an immunosuppressive microenvironment. Our results provide a systematic landscape of molecular profiles that drive LUAD subtype progression, and demonstrate potentially novel therapeutic strategies and targets for invasive lung adenocarcinoma.
惰性(鳞屑样)和侵袭性(微乳头、实体和低分化腺泡)组织学亚型通常共存于肺腺癌(LUAD)的肿瘤组织中,但与不同亚型及其转变相关的分子特征仍不清楚。在这里,我们结合空间转录组学和多重免疫组化来阐明LUAD不同组织学亚型的分子特征和细胞可塑性。我们描绘了决定亚型进展的转录重编程和动态细胞信号传导,特别是缺氧诱导的调节网络。不同的组织学亚型在去分化状态上表现出异质性。此外,我们的结果表明巨噬细胞是LUAD中最丰富的细胞类型,并确定了每种组织学亚型特有的不同肿瘤相关巨噬细胞亚群,这可能有助于形成免疫抑制微环境。我们的结果提供了驱动LUAD亚型进展的分子图谱的系统概况,并展示了侵袭性肺腺癌潜在的新治疗策略和靶点。
J Thorac Oncol. 2020-12
Clin Transl Med. 2025-8
Cancers (Basel). 2025-6-9
Nat Rev Clin Oncol. 2025-5-16
Nat Methods. 2022-2
Cell. 2021-6-24
Circulation. 2021-7-27
Curr Opin Syst Biol. 2021-6